MORE►
rare diseases
Samuel Barone, M.D., is a former Federal Drug Administration official and leader in the pharmaceutical space.
Nanoscope Therapeutics Strengthens Clinical, Regulatory Expertise with Appointment of Chief Medical Officer
by Lance Murray | Sep 22, 2023
Samuel Barone, M.D., is a former Federal Drug Administration official and leader in the pharmaceutical space.
by David Kirkpatrick |
Jan 31, 2022
Only five other U.S. companies have received ACHC accreditation as specialized pharmacies with distinction in rare disease and orphan drugs. Founded in 2014, Soleo debuted on the Inc. 5000 for the first time in 2020. With 20 locations nationwide, Soleo delivers specialty pharmacy and infusion services, with a focus on amyotrophic lateral sclerosis (ALS), thyroid eye disease (TED), hemophilia, muscular dystrophy, and myasthenia gravis.
MORE►
